Scavenger receptor class B Type I (SR-BI) assembles into detergent-sensitive dimers and tetramers

Biochimica Et Biophysica Acta
Daisy SahooM A Connelly

Abstract

High density lipoproteins (HDL) are protective against cardiovascular disease due to their important role in the reverse cholesterol transport (RCT) pathway. The selective transfer of cholesteryl ester (CE) from the HDL core to cells, the last step in RCT, is mediated by scavenger receptor class B type I (SR-BI). SR-BI is a heavily glycosylated cell surface receptor that is highly expressed in the liver, ovaries, testes and adrenal glands, where selective uptake of HDL-CE is most prevalent. Previous studies have shown that SR-BI oligomerizes with itself in steroidogenic tissues as well as in diverse cell lines. In the present study, we provide further evidence for the homo-oligomerization of SR-BI. We show by FPLC and blue native PAGE that SR-BI forms complexes whose sizes suggest the formation of monomers, dimers, and tetramers. Interestingly, homo-oligomerization occurs even with the absence of SR-BI's C-terminal cytoplasmic domain. Finally, we report that an inhibitor of SR-BI-mediated cholesterol transport, BLT-1, and mutations in the putative leucine zipper region of SR-BI have profound effects on SR-BI function, however, they do not affect receptor self-association. These observations indicate that SR-BI homo-oligomerizat...Continue Reading

References

Jan 1, 1986·Methods in Enzymology·T VanAkenS Ferguson-Miller
Nov 14, 1997·Proceedings of the National Academy of Sciences of the United States of America·A RigottiM Krieger
May 16, 1998·Proceedings of the National Academy of Sciences of the United States of America·M L VarbanD Huszar
Mar 15, 2000·Journal of Molecular Biology·W P Russ, D M Engelman
Nov 20, 2002·Proceedings of the National Academy of Sciences of the United States of America·Thomas J F NielandTomas Kirchhausen
Jan 17, 2003·The Journal of Biological Chemistry·Jianguo XuRandy A Hall
Jan 21, 2003·The Journal of Biological Chemistry·M Rachel RichardsJean E Schaffer
Sep 2, 2003·Current Opinion in Structural Biology·A Rachael Curran, Donald M Engelman
May 14, 2004·The Journal of Biological Chemistry·Hideaki KankiDan M Roden
Jun 24, 2004·Proceedings of the National Academy of Sciences of the United States of America·Nan WangAlan R Tall
Aug 28, 2004·The American Journal of Pathology·Miranda Van EckTheo J C Van Berkel
Jan 15, 2005·Current Opinion in Lipidology·Ji-Young Lee, John S Parks
May 14, 2005·Current Opinion in Lipidology·Shinji Yokoyama
May 14, 2005·Current Opinion in Lipidology·Miranda Van EckTheo Jc Van Berkel

❮ Previous
Next ❯

Citations

Jun 20, 2007·European Biophysics Journal : EBJ·Stéphane OrlowskiXavier Collet
Jan 25, 2011·Biochemistry·Thomas J F NielandMonty Krieger
Jul 13, 2011·Proceedings of the National Academy of Sciences of the United States of America·Miao YuMonty Krieger
Oct 16, 2009·Journal of Virology·Maria Teresa CataneseAlfredo Nicosia
Oct 3, 2012·PloS One·Alexandra C Chadwick, Daisy Sahoo
Feb 14, 2013·Current Opinion in Endocrinology, Diabetes, and Obesity·Alexandra C Chadwick, Daisy Sahoo
Sep 4, 2008·Proteomics·Ilka Wittig, Hermann Schägger
Jul 16, 2010·Cell Biochemistry and Function·To Quyen TruongLouise Brissette
Mar 3, 2009·Biochimica Et Biophysica Acta·Julie C RobichaudDennis E Vance
Oct 9, 2008·Molecular and Cellular Endocrinology·Margery A Connelly
May 30, 2007·Journal of Lipid Research·Thomas J F NielandMonty Krieger
Jan 22, 2010·Arteriosclerosis, Thrombosis, and Vascular Biology·Sonika SaddarPhilip W Shaul
Mar 7, 2019·The Biochemical Journal·Sarah C Proudfoot, Daisy Sahoo
Feb 5, 2021·Circulation Research·Nada A AbumradIra J Goldberg
Oct 8, 2021·Arteriosclerosis, Thrombosis, and Vascular Biology·Bernardo L Trigatti
Mar 12, 2010·Archives of Biochemistry and Biophysics·Gabriella A PapaleDaisy Sahoo
Feb 3, 2022·Current Atherosclerosis Reports·Hayley R Powers, Daisy Sahoo

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.